Author:
Chandna Pooja,Khandare Jayant J.,Ber Elizabeth,Rodriguez-Rodriguez Lorna,Minko Tamara
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference33 articles.
1. Piver MS. 16, 090: the 2004 estimated U.S. mortality from ovarian cancer. Gynecol Oncol. 2005;97(1):301–2.
2. de Vries EG, Hamilton TC, Lind M, Dauplat J, Neijt JP, Ozols RF. Advanced ovarian cancer. Drug resistance, supportive care and dose intensity. Ann Oncol. 1993;4 Suppl 4:57–62.
3. Baekelandt M, Kristensen GB, Nesland JM, Trope CG, Holm R. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J Clin Oncol. 1999;17(7):2061–8.
4. Herod JJ, Eliopoulos AG, Warwick J, Niedobitek G, Young LS, Kerr DJ. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res. 1996;56(9):2178–84.
5. Mano Y, Kikuchi Y, Yamamoto K, Kita T, Hirata J, Tode T, et al. Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. Eur J Cancer. 1999;35(8):1214–9.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献